Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Post-Transplant Use of Irradiated Haplo-Allogeneic Cells

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03272633
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:05.862398+00:00
Published At
2023-06-26T00:00:00+00:00
Record Updated At
2023-06-26
Results Posted At
2023-06-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia in Remission", "Hematopoietic Cell Transplantation Recipient", "JAK2 Gene Mutation", "Loss of Chromosome 17p", "Mantle Cell Lymphoma", "Minimal Residual Disease", "Myelodysplastic Syndrome", "Non-Hodgkin Lymphoma", "Plasma Cell Myeloma", "RAS Family Gene Mutation", "Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent Hematologic Malignancy", "Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma", "Refractory Diffuse Large B-Cell Lymphoma", "Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "Therapy-Related Acute Myeloid Leukemia", "Therapy-Related Myelodysplastic Syndrome", "TP53 Gene Mutation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-06-26"
protocolSection.identificationModule.nctId
"NCT03272633"
protocolSection.identificationModule.officialTitle
"Post-Transplant Use of Irradiated Haplo-Allogeneic Cells"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-06-26"

Study condition terms

  • Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Hematopoietic Cell Transplantation Recipient (protocolSection.conditionsModule.conditions)
  • JAK2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • Loss of Chromosome 17p (protocolSection.conditionsModule.conditions)
  • Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Minimal Residual Disease (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Plasma Cell Myeloma (protocolSection.conditionsModule.conditions)
  • RAS Family Gene Mutation (protocolSection.conditionsModule.conditions)
  • Recurrent Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Hematologic Malignancy (protocolSection.conditionsModule.conditions)
  • Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Therapy-Related Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Therapy-Related Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • TP53 Gene Mutation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.